English

• 24 Aug, 2021
  Spago Nanomedical interim report January-June 2021
• 3 Aug, 2021
  Spago Nanomedical appoints Paul Hargreaves as Chief Development Officer
• 5 May, 2021
  Bulletin from the 2021 Annual General Meeting of Spago Nanomedical AB (publ)
• 28 Apr, 2021
  Spago Nanomedical interim report January-March 2021
• 13 Apr, 2021
  Årsredovisning 2020
• 26 Mar, 2021
  Trading of Spago Nanomedical shares on Nasdaq First North Growth market starts today
• 7 Dec, 2020
  Extended SpagoPix patent protection in Europe
• 12 Nov, 2020
  Invitation to webcast
• 12 Nov, 2020
  Distinct images in clinical study with SpagoPix
• 24 Aug, 2020
  Spago Nanomedical appoints candidate drug in the Tumorad® project